Cargando…
SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes
BACKGROUND: Prognosis of esophageal squamous cell carcinoma (ESCC) patients is poor and the concurrent chemoradiation therapy (CCRT) provided to ESCC patients often failed due to resistance. Therefore, development of biomarkers for predicting CCRT response is immensely important. In this study, we e...
Autores principales: | Kuo, I-Ying, Huang, Yu-Lin, Lin, Chien-Yu, Lin, Chien-Hsun, Chang, Wei-Lun, Lai, Wu-Wei, Wang, Yi-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378712/ https://www.ncbi.nlm.nih.gov/pubmed/30777052 http://dx.doi.org/10.1186/s12929-019-0510-4 |
Ejemplares similares
-
MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma
por: Lin, Cheng-Han, et al.
Publicado: (2016) -
Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma
por: Hsieh, Chih-Hsiung, et al.
Publicado: (2022) -
High-CLDN4 ESCC cells harbor stem-like properties and indicate for
poor concurrent chemoradiation therapy response in esophageal squamous cell
carcinoma
por: Lin, Cheng-Han, et al.
Publicado: (2019) -
Histopathological and Haemogram Features Correlate with Prognosis in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation without Pathological Complete Response
por: Huang, Yu-Ming, et al.
Publicado: (2022) -
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
por: Matani, Hirsch, et al.
Publicado: (2022)